From OTCQX’s CEO Video Series, this interview features Brad Thompson, CEO of Oncolytics Biotech, and Bob Power, OTC Markets Group vice president.
In this video interview, Brad Thompson discusses Oncolytics Biotech’s current advances in cancer therapy, future pipeline and the benefits of cross-listing in the US.
This content is provided by OTC Markets and did not involve IR Magazine journalists.
